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The effect of the antifungal imidazole co mpound, clotri-
mazole, on th e metabolism of benzo[a ]pyrene (BP) w as 
studied in cultured keratinocytes prepared from BALB/c 
mouse epidermis . Varying concentrations of clotrimazole 
added to the cultured keratinocytes resulted in a dose-
dependent inhibition of the activities of the microsomal 
cytochrome P-4S0-dependent monooxygenases aryl hy-
drocarbon hydroxylase and 7-ethoxycoumarin O -deethyl-
ase . T he major organic solvent-soluble metabolites of BP 
identified in the cultured cells were trans-7,8-dih y dro-
7,8-dih ydroxybenzo[a]pyrene (BP-7,8-diol), 9-hydroxy-
benzol a ]pyrene (9-0H-BP), and 3-hydroxybenzo[ a ]py-
rene (3-0H-BP) , although small amounts of Irans-4,S-
dihydro-4,S-dihydroxybenzo[a ]pyrene, BP-quinones, and 
lrans-9, lO-dihydroxybenzo[a ]pyrene were also present. The 
major organic solvent-extractable metabolites ofBP found 
in the extracellular culture medium w ere primarily the diols 
with smaller quantiti es of phenols and quinones. The major 
water-soluble metabolites of BP present both intracellu-
larl y and extracellularl y were glu curonide conjuga tes of 3-
Polycycl ic aro matic hydrocarbons (PA Hs) such as benzo[a]pyrene (BP) are ubiquitous environmental pol-lutants occurrin g primarily as a result of the incomplete combustion of organic substances [1, 2]. It is generally accepted that the mutagenic [3], cell-transforming [4], 
DNA alk ylation [5], and carcinogenic [6] effects of BP require 
its metabolic activation. This metabolic activation is initi ated by 
a membrane-bound microsomal enzyme system which utilizes 
the hemeprotein cytochro me P-450 as its terminal oxidase [7,8]. 
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Abbreviations: 
AHH: aryl hydroca rbon hydroxylase 
BA : benz[aJanthraccne 
BP: benzola]pyrene 
BP-4.5-diol: (± )-tralls-4.5-dihydro-4, 5-d ih ydroxybenzo[a ]pyrene 
BP-7,8-diol: ( ± )-tralls-7.8-dihydro-7.8-dihydroxybenzo[aJpyrenc 
OH-BP, 9-0H-BP, and benzo[a]pyrene-3,6-dione and to 
a lesser extent sulfate conjugates (primarily of the BP-7,8-
diol) . C lotrimazole inhibited the generation of organic sol-
vent-soluble and water-soluble conjugates in a dose-de-
pendent manner. The in vitro metabolism ofBP by micro-
somes prepared from control and benz[ a ]anthracene (BA)-
induced cultured keratinocytes was also inhibited by clo-
trimazole with greater inhibitory effect on BA-induced ke-
ratinocytes especially with respect to the formation of diols 
and quinones . The enzyme-mediated covalent binding of 
BP to mouse keratinocyte DNA and protein was also sub-
stantially diminished by clotrimazole in a dose-dependent 
fashion . These results indica te that clotrimazole, a widely 
used drug for the management of a variety of superficial 
dermatophyte infections of the skin, is a potent inhibitor 
of cytochrome P-4S0-dependent transformation of poly-
cyclic aromatic hydrocarbons in cultured murine keratino-
cytes. This system offers a convenient approach for studies 
as inhibitors of carcinogen metabolism in the epidermis. ] 
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Generally known as the monooxygenase system, this enzyme 
complex is ca pable of transforming BP into a variety of arene 
oxides or epoxides which are subsequently hyd rolyzed by another 
enzyme, epoxide hydrolase, to dihydrodiols [8]. These diols can 
be either eliminated by sulfation of glucuronidation or undergo 
further metabolism by the cytochrome P-450 system to diol-
epoxides [8-11] . It is cu rrently believed that one of these diol-
epoxides known as 7,8-dihydroxy-9, 1 O-epoxy-7,8, 9,1 O-tetrahy-
drobenzo[a ]pyrene (BP-7,8-diol-9, 1 O-epoxide) is the ultimate 
carcinogenic metabolite ofBP that can bind covalently to cellular 
BP-9, 1 O-diol: (± )-tra/ls-9, 1 0-dihydro-9, 1 0-
dihydroxybenzolll ]pyrene 
BP- l .6-qllinone: bcnzo[a ]pyrene-l .6-dione 
BP-3,6-qllinone: benzo[aJpyrene-3.6-dione 
BP-7.8-dio l-9.IO-epoxide: 7,8-dihydroxy-9. 10-cpoxy-7, 8, 9, 10-
tetrahydrobenzo[ a Jpyrcne 
EC D: 7-cthoxycoumarin O-deethy lasc 
HPLC: high-pressure liquid chromatography 
3-MC: 3-methylcholanthrene 
3-0H-BP: 3-h ydroxybenzo[a ]pyrcne 
9-0H-BP: 9-h ydroxybenzo[a ]pyrenc 
PAH: polycyclic aromatic hydrocarbon 
PBS: phosphate-buffered sa line 
TCA: trichlo roacetic acid 
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macromolecules including DNA, thereby initiating the process 
of carcinogenesis [12,13]. 
Skin is one of the major target tissues for BP carcinogenesis 
[14,15] and cutaneous tissue has been shown to possess substantial 
capacity for the metabolic biotransformation of xenobiotics in-
cluding BP [16] . Beca use the metabolism of BP is an important 
event in the initiation of skin cancer, inhibito rs of the metabolism 
of this compound could prove useful as anticarcinogens. Recent 
studies have shown that the use of cell cu lture systems and studies 
of neoplastic transformation in such cells offer a convenient ap-
proach for developing important new information relatin g to the 
mechanism of chemical ca rcinogenesis (17 ,19]. Major differences 
that ha ve been observed among cells prepared from various tissues 
and species [20-22] reemphasize the importance of studyin g bo th 
activation and detoxification pathways ofPAHs and th eir mod-
ulation in specific target tissues. 
It is now known that certain dietary factors and synthetic chem-
icals can playa vital role in the modulation of the oncogenic 
effects of certain environmental carcinogens [23-25]. For exam-
ple, it has been shown that the imidazole-containing compounds , 
among them certain widely used drugs such as cimetidine, ben-
zimidazole, and c1otrimazole, can alter hepatic xenobioti c metab-
olism by inhibiting the cytochrome P-450-dependent monooxy-
genase system [26-28]. C lotrimazole is currently in widespread 
clinical use as a topically applied antifungal agent for the man-
agement of a w ide variety of superficial dermatoph yte infections 
[29] . In recent studies we have shown that c1otrimazole is a potent 
inhibitor of BP metabolism and 3-methylcholanthrene (3-MC) 
induced skin carcinogenesis in BALBlc mice [30]. In thjs study , 
we have extended these studies to keratinocytes cultured from 
BALBlc mouse epidermis and show that c1otrimazo le is a strong 
inhjbitor of BP metabolism and its subsequent enzy me-mediated 
covalent binding to cel lular macromolecules in these cells. 
MATERIALS AND METHODS 
Chemicals [G-3H]BP (sp act 21 Ci/mmol) was purchased from 
Amersham Searle (Chicago, Illinois). Prior to use the radiolabeled 
BP was purified using a silica gel (Partisil1 0 /-L, Waters Associates) 
column with hexane as the eluting solvent and subsequently by 
reverse phase high-pressure liquid chromatography (HPLC) using 
a Dupont Zorbax ODS column (0.2 mm X 25 cm) eluted with 
methanol: water (19: 1, v/v). The purity of the BP was g reater 
than 99% as judged by HPLe. BP reference standards were pro-
vided by the Cancer Research Program of the N ational C ancer 
Institute (Bethesda, Maryland). C lotrimazole, protease K (Type 
XI), m-cresol, 8-hydroxyquinoline, NADPH , ribonuclease A 
(Type III-A), .a-glucuronidase, aryl sulfatase, ascorbic acid, and 
D-saccharic acid- 1, 4-lactone were purchased from Sigma C hem-
ical Co. (St. Louis , Missouri). Pure (> 99%) phenol was a product 
of Aldrich Chemical Co. (Milwaukee, Wisconsin). All solvents 
used were of HPLC grade and were purchased from Fisher Sci-
entific Co. (Fairlawn, N ew J ersey). All other chemicals were of 
the highest purity commercially available. 
Preparation of Epidermal BALB/c Mouse Keratinocytes and 
Incubation with [3H]BP A primary neonatal BALBlc mouse 
keratinocyte culture system as described by Marcelo et al [31] 
was employed. Briefly, whole skins are isolated from 2- to 3-
day-old mice and the epidermis separated from the dermis by 
0.25% trypsinization at 37"C for 1 h . The cells were then purified 
using a discontinuous Ficoll g radient and the basal cell-enriched 
fraction plated onto T -75 flasks containing Medium 199, feta l 
bovine serum, and phosphate-buffered saline (PBS) . Two days 
after plating, when the cells were in the proliferative phase, media 
were removed and fresh media (30 ml/flask) containing varying 
concentrations of c1otrimazole (2-10 /-LM) in acetone (0.25 ml) 
added to the culture flasks and incubated for 4 h at 37"e. Identical 
volumes of acetone were added to other flasks which served as 
controls. [3H]BP (1 /-Lg/ml in 60 /-LI of acetone, sp act = 1.25 
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C i/ mmol) was then added to the medium and incubated for 
24 h at 37°C in 5% CO2 in air. The culture medium was removed 
from the cells fo r analysis of extracellular metabolism ofBP after 
which the remaining monolayers were rinsed 3 times with PBS 
and harvested in cold PBS (4°C) using a rubber po liceman. All 
subsequent steps were ca rried out at 0-4°C. The collected cells 
were was hed twice with PBS by centrifu ga tion at 800 g for 5 
min. The sedimented cells were res uspended in 0.1 M phosphate 
buffer, pH 7.4, containing 10 mM EDT A, 10 mM dithiothreitol, 
and 20% (v /v) glycerol and sonica ted for six 10-s bursts with a 
Heat Systems son icator equipped with a microprobe. A 30-s in-
terval between each burst minimized heatin g of the cells. The 
soni ca ted cell suspensions were frozen overni ght at - 170°C under 
nitrogen and were subseq uently thawed for use in assessin g DN A 
and protein binding, enzy me activity, and for metabo lic studies. 
In some experiments benz[a]anthracene (BA) (4 x 10- 4 M) was 
add ed to the cells in the proliferative phase. The cells were then 
incubated fo r 24 h at 37°C after which cell suspensions were 
prepared as described above. Microsomes were prepared from 
control and BA-induced keratinocyte suspensions as described 
ea rlier [32]. T he effect of c1otrimazolc on the microsomal me-
tabolism of BP w as studied in contro l as wel l as in BA-induced 
cultured keratinocytes. 
Enzyn'le Assays A microassay for estimat ing aryl hydrocarbon 
hydroxyl ase (AHH) activity in kerat inocyte cell homogenates 
prev iously developed in our laborato ry was employed [33]. T his 
assay procedure was based on the o rig inal procedure of N ebert 
and Gelboin [34]. The measurement of phenolic BP metabolites 
was based on comparison w ith flu orescence of a 3-hydroxy-
benzo[a]pyrene (3-0H-BP) standard. 7-Ethoxycoumarin 0 -
deethylase (ECD) activity was determined acco rdin g to a slight 
modifi cation of th e procedure of Greenlee and Poland 1351. the 
details of which were described ea rlier 133]. Metabolite formation 
was ca lculated in comparison with an auth entic standard of 7-
OH-coul11arin . Protein was determined by the procedure of Lowry 
et al [36] using bovine serum albumin as a reference standard. 
Extraction ofIntra- and Extracellular Metabolites ofBP The 
proced ure for extraction of intra- and extracellular metabolites of 
BP was essentia ll y similar to that described previously by Di-
Giovanni et al [37] with severalmodiftcations as described below. 
Fo r the purpose of this investigation the term intracellular refers 
to total metabolites as identified by the radioa ctivity associated 
with the cell membranes whi le extracellular refers to total metab-
olites in the culture medium in terms of the amount of radioac-
tivity that has diffused out o f the cells. Keratinocyte suspensions 
and supernatant media were extracted with ethyl acetate: acetone 
(2: 1, v/v) as described ea rlier [21] . T he recovery of to tal rad io-
activity was grea ter than 90%. 
Both ho mogenates and media sa mples were furth er analyzed 
for the presence of glucuronide and sul fa te conju gates of BP me-
tabolites as described by DiGiovanni et al [37]. For the deter-
mination of glucuronide conjuga tes, 1 ml of homogenate o r cul-
ture medium was combined with 1 ml of 0.1 M potassium phosphate 
buffer pH 6.8 and incubated at 37°C fo r 2 h with 4000 Fishman 
units of .a-g lucuronidase. The addition of20 mM D-saccharic acid 
1,4-lactone completely inhibited the release of glucuronide con-
jugates under these conditions. In addition, ascorbic acid (1 mg/ ml) 
was routinely added to incubations to prevent spontaneous oxi-
dation of phenols to quinones. For the determination of sul fa te 
conju gates, 1 ml of the cell ho mogenate or medium was combined 
with 1 ml of 0.2 M sodium acetate buffer pH 5.0 and incubated 
at 37°C for 4 h with 60 units of aryl sulfatase plus 20 mM 
I)-saccharic acid 1,4-lactone. After incubation , the reacti ons were 
t(mninated by adding 2 vol of ice-cold ethyl acetate: acetone (2: 1, 
v/v). Samples were then centrifu ged and the o rganic phase dried 
under a stream of nitrogen, dissolved in 0.1 IllI of methanol, and 
ana lyzed by HPLC for metabolite identifica tion and quantitation . 
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Table I. Metabolism of BP by BALB/c Mouse 
Cultured Keratinocytes 
Metabolite" 
Organic solvent soluble 
Diols 
Quinones 
Phenols 
Aqueous soluble 
Glucuronide 
conjugated 
Sulfate conjuga ted 
Total Intracellular 
Metabolite/'" 
6,594 ± 516" (3.82) 
5, 11 8 ± 618 (2.96) 
16,248 ± 1,188 (9.40) 
1,410 ± 240 (0.82) 
414 ± 24 (0.23) 
Total Extracellular 
Metabolited 
7,539 ± 639 (4.36) 
1,428 ± 123 (0.83) 
1,965 ± 126 (1.14) 
396 ± 27 (0.23) 
309 ± 24 (0. 18) 
"Ex tracted materia l was ana lyzed on HPLC for the identification ofB I' metabolites 
as described in Materials alld Methods. 
'Flasks containin g cells and .cetone (control sa mples only) we re incubated for 4 
h at 37°C. I' H]BP (I ILg/ ml) w.s th en added to the culture mediul11 and incubated 
for 24 h at 3rc. Cell homogenates were prepared and subseq uentl y ex tracted or 
digested with enzymes as descri bed in Materials alld Methods. 
'Tota l intracellular metabo lite formation was calculated by multiplying the pmo l 
metabolite/24 h/ mg protein wi th the total protein in the cell homogenates. The 
protein content in the Aask ranged fro m 10.6-15.3 mg. 
"Total extracellular metabolite fo rmation was calcu latcd by multipl ying the pl110l 
metabolite124 h/ ml media wi th the tota l volume (30 ml) of culture media. 
' Data represent mean :!: SEM of 4 different Aasks. Values in parenthesis represent 
the percent metabo lite formation of the tOta l dose of BP in the culture medium . 
High-Pressure Liquid Chromatography Analysis of BP 
Metabolite Formation A Waters Associates model 204 liquid 
chromatograph, fitted with a Waters Associates J.LBondapak C IS 
column (4.6 mm X 25 cm) was used for the analysis of radio-
labeled metabolite mixtures of BP. Identification of metabolites 
was based on reference standards. The column was eluted at 
ambient temperature with a 30- min linear gradient of metha-
nol : water: tetrahydrofuran (70: 27: 3, v/v) to methanol at a sol-
vent flow rate of 0.8 mllmin [38], T he eluates were monitored 
at 254 nm, fractions of approximately 0.2 ml were collected drop-
wise, and the radioactivity of each fraction was determined on a 
Packard TriCarb 460 CD liquid scintill ation spectrometer. The 
counting efficiencies of the early eluted fractions, containing a 
higher percentage of water, were about 2% lower than those of 
the fract ions with methanol. The amount ofthe material released 
by ,B-glucuronidase or aryl sulfatas e treatment of the keratinocyte 
homogenates or culture medium was determined by subtrac ting 
the chromatographic profiles of the organic-solvent soluble me-
tabolites of untreated samples from the chromatographic profiles 
of ,B-glucuronidase- or aryl sul fa tase-trea ted samples. 
Covalent Binding of [3H]BP to Keratinocyte DNA DNA 
was extracted from sonicated cell homogenates essentially as de-
scribed by Kates and Beeson [39], with an additional incubation 
step usin g protease K (0.5 mg/ml) . A second extraction was per-
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formed using Kirby's phenol [40] before precipitation with cold 
100% ethanol. The DNA was then digested with ribonuclease A 
(1000 units / ml), washed 3 times w ith acetone, and dried under a 
stream of nitrogen. Extracted DNA was then dissolved in 5 ml 
of 0.1 M sodium chloride pH 7.0 and estimated by measurin g its 
abso rbance at 260 nm . The purity of the DNA was assessed by 
the absorban ce ratios A260/ A280 ~ 1.98 and A260/ A230 ~ 2.21 
[41]. Aliquots of purified D NA were then measured by liquid 
scintillation spectrom etry to determine the amount of [3H]BP 
bound to cellular DNA. 
Covalent Binding of [3H]BP to Keratinocyte Protein The 
protein from an aliquot of the sonicated cell homogenates was 
precipitated by addin g 10% trichloroacetic acid (TCA) . The pre~ 
cipitated protein was then washed 3 times with ethyl acetate and 
subsequently 3 times with acetone. The las t washing from acetone 
possessed no radioactivity in the supern atant. The protein thus 
obtained was dissolved in 1 ml of 1 N N aO H . The protein in the 
samples was assayed according to Lowry et al [36] and the aliquots 
were counted to determine the amount of [3H]BP bound to cel-
lular protein . 
RESULTS 
Metabolism ofBP in Cultured Keratinocytes T able I shows 
the total as well as percent distribution of the intracellular and 
extracell ular metabolites of BP in cultured cells. The total me-
taboli tes of BP measured in the cell s and in the extracellular m e-
dium were 17.48% and 6,74%, respectively . Analysis of the or-
gani c solvent-extractable in tracellular metabolites indicated that 
phenol s were present in highest concentra tion followed by diols 
and quinones. The formation of glucuronide and sul fate conju-
gates of BP metabolites in the intracellular aqueous portion were 
0.82% and 0.23%, respectively (Table I). The organ ic solvent-
soluble extracellular metabolic profde showed that BP-diols were 
formed in highest concentration fo llowed by phenols and qui-
nones (T able I) . The glucuronide and sulfate conju gates of BP 
metabolites measured in the extracellular medium were 0.23% 
and 0.18%, respectively. 
Effect of Clotrimazole in BP Metabolism in Microsomes 
Prepared from Control and BA- Induced Cultured 
Keratinocytes T he effect of the addition of c1otrimazole (1.5 
J.LM) on BP m etabolism in microsomes prepared from control and 
BA-treated mouse keratinocytes is depicted in Table II. Pretreat-
ment of the cultured cell s with BA caused a substantial increase 
in the metabolism of BP (Table II) . The formation of BP-diols , 
BP-quinones, and BP-phenols was increased 1,8- to 2. 3-fold, 1.6-
to 1. 8-fold , and 3.8- to 6.6-fold, respectively, following the ad-
dition of BA to the cells. Addition of c1o trimazole to the micro-
somes from control cells caused 80%, 77%, 58%, 38%, 32%, 
and 28% inhibition of 3-0H-BP, 9-0H-BP (9-hydroxy-
Table II. In Vitro Effect of C lotrimazole on BP Metabolism in Microsomes Prepared from Control and BA-Induced 
C ultured Keratinocy tes 
Contro l BA-Induced 
Without With Percent Without With Percent 
Metabolites' C lo trimazole Clo trimazole Inhibition Clotrimazole C lo trim azole Inhibition 
9,10-Diol 10.6 ± 1. 3 4.5 ± 0.2 58 24.2 ± 2.6 10.3 ± 1.1 57 
4,5-Diol 6. 1 ± 0.3 3.8 ± 0.4 38 10.8 ± 1.3 4.4 ± 0.2 58 
7,8-Diol 39.2 ± 3. 1 24.4 ± 1.7 38 86.7 ± 7. 8 23.5 ± 1. 3 73 
1,6-Quinone 9.3 ± 0.5 6.3 ± 0.7 32 16.8 ± 1.2 9. 1 ± 0. 5 46 
3,6-Quinone 7.8 ± 0.9 5.6 ± 0.4 28 12.7 ± 0.9 7.3 ± 0.2 43 
9-Hydroxy 58.7 ± 4.9 13.3 ± 1.4 77 225.5 ± 23.5 49.8 ± 3.8 78 
3-H ydroxy 103.4 ± 8.8 20.8 ± 1. 8 80 684.0 ± 58.6 88.3 ± 9.3 87 
Keratinocytes were cultured from 3-day-old animals as described in Material alld Methods. Benz[a]anthracene (4 X }O- < M) was added in 100 ILl acetone 24 h before th~ 
cells were harvested. Contro l Aasks received the solvent alone. Microsomes were prepared from control and BA-treated cu ltures. The effects of c1otrimazoic (1.5 X }O- 6 M) 
on the microso mal metabolism of [3H]BP was studied. BP metabolites were ex tracted and identified as described under Materials alld Methods. Data represent mean :!: SEM 
of 3 individual ex periments. 
'p111ol metabolite/30 min/mg protein. 
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benzo[a]pyrene), BP-9,10-diol (( ± )-tral1s-9, 10-dihydro-9, 10-di-
hydroxybenzo[ a ]pyrene). BP-4,5-diol (( ± )-tral1s-4,5-dihydro-4,5-
dihydroxybenzo[a]pyrene), BP-7,8-diol (( ± )-tral1s-7,8-dihydro-
7, 8-dihydroxybenzo[a ]pyrene), BP-l,6-quinone (benzo[ a] 
pyrene-l,6-dione), and BP-3,6-quinone (benzo[a]pyrene-3,6-dione) 
metabolite formation, respectively . Clotrimazole (1.5 /LM) also 
inhibited the metabolism ofBP in the microsomes ofBA-treated 
cells. Interestingly , inhibition of the formation ofBP-4, 5-diol and 
BP-7,8-diol was 58% and 73%, which was greater than the in-
hibition observed in microsomes from control cells (38% and 
38%), respectively (Table II) . 
Effect of Clotrimazole on Monooxygenase Activities in 
Cultured Keratinocytes The effect of clotrimazole on mono-
oxygenase activities in the cultured keratinocytes is shown in Fig 
1. A dose-dependent inhibitory effect of clotrimazole on AHH 
and ECD activities was observed in the cells. Following the ad-
dition of 2, 5, or 10 /LM concentrations of clotrimazole, AHH 
activity was inhibited 36%, 53%, and 69%, respectively; ECD 
activity was inhibited by 40%, 54%, and 79%, respectively (Fig 
1). These data suggest that clotrimazole diffuses into the cells 
where it can exert an inhibitory effect on the membrane-bound 
cytochrome P-450-dependent monooxygenase system. Clotri-
mazole had no detectable toxic effects on the cultured cells at any 
concentrations employed as judged by measuring [3H]thymidine 
incorporation into the cells (data not shown). 
Effect of Clotrimazole on the Intracellular Metabolism of 
BP in Mouse Keratinocytes A dose-dependent effect of clo-
trimazole on the intracellular metabolism of BP in the cultured 
cells is shown in Fig 2. At a concentration of 2 /LM, clotrimazole 
decreased the formation of all metabolites of BP by more than 
50%. The formation of 3-0H-BP, 9-0H-BP, and BP-7,8-diol 
was decreased by 59%, 56%, and 55% , respectively. Fig 2B shows 
the effect of varying concentrations of clotrimazole on the amount 
of intracellular glucuronide-conjugated metabolite formation of 
BP by primary cultures of mouse keratinocytes. Glucuronide 
conjugation with 3-0H-BP, 9-0H-BP, BP-7,8-diol, and BP-3,6-
quinone was decreased 72%, 60%, 60%, and 64%, respectively, 
by clotrimazole (2 /LM) (Fig 2B). The effect of increasing con-
centrations of clotrimazole on the intracellular formation of sulfate 
conjugates of BP metabolites in keratinocytes is depicted in Fig 
2C. It is of interest that the major sulfate conjugate of BP is the 
metabolite BP-7,8-diol. At the lowest concentration of clotri-
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Figure 1. Effect of c1otrimazole on AHH (solid circles) and ECD (opel/ 
circles) activities in mouse keratinocytes. Mouse keratinocyte cultures were 
incubated with vehicle (control) or varying concentrations (2-10 f-LM) of 
clotrimazole in acetone (0.5 ml) for 4 h at 37°C. Cellular homogenates 
were prepared and used as enzyme source. The reaction was started by 
adding substrates as described in Materials and Methods. Values represent 
specific activity of AHH and ECD from 4 separate experiments. 
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mazole tested (2 /LM) , sul fa te conjugates of BP-7,8-diol, BP-4,5-
diol, BP-9,10-diol, and 3-0H-BP were decreased by 65%,69% , 
60%, and 64%, respectively. 
Effect of Clotrimazole Extracellular Metabolites of BP in 
Mouse Keratinocytes In further experiments, the effect of dif-
ferent concentrations of clotrimazole on the amount of BP me-
tabolites released in the culture medium was assessed. As shown 
in Fig 3 increasing concentrations of clotrimazole decreased the 
formation of organic solvent-soluble metabolites ofBP. The ma-
jor organic solvent-extracta ble metabolites of BP in the extra-
cellular medium were BP-7,8-diol, BP-9,1O-diol , BP-4,5-diol, 
and 3-0H-BP. The occurrence of all these metabolites was de-
creased by 56%, 54%, 36%, and 44% , respecti vely, at 2 J-LM 
concentration of clotrimazole (Fig 3A). The effect of clotrimazole 
on the formation of water-soluble metaboli tes of BP conju ga ted 
with glucuronide into the extracellular medium is depicted in Fig 
3B. The formation of glucuronide conjugates of 3-0H-BP, 
9-0H-BP, and BP-3,6-quinone in the extracellular medium was 
decreased 53%, 60%, and 46%, respectively, by 2 /LM concen-
tration of clotrimazole (Fig 3B). The concentration-dependent 
effect of clotrimazole on the formation of sulfate conjugates of 
BP extracellularly is depicted in Fig 3C. The sul fate conjugates 
of BP were mainly diols. C lotrimazole (2 J-LM) decreased the for-
mation of sulfate conjugates of BP-7,8-diol , BP-9, 1 O-diol, and 
BP-4,5-diol by 66%, 53% , and 73%, respectively, in the extra-
cellular medium (Fig 3C). 
Effect of Clotrimazole on the Covalent Binding of BP to 
Macromolecules of Mouse Keratinocytes Figure 4 shows the 
effect of clotrimazole on the covalent binding of BP to kerati-
nocyte DNA and protein. C lotrimazole caused a concentration-
dependent inhibition of enzyme-mediated covalent binding of BP 
to keratinocyte DN A. C lotrimazole (2 /LM) inhibited the binding 
ofBP to DNA by 33% (Fig 4). Clotrimazole also showed a dose-
dependent inhibitory effect on the covalent binding ofBP and /or 
its metabolites to TCA-precipitable keratinocyte protein (Fig 4). 
The inhibition of protein binding at 2 /LM concen tration of clo-
trimazole was 30%. 
DISCUSSION 
Cell culture systems offer an important alternative approach to 
in vivo animal studies in assessing the metabolism of chemical 
carcinogens in target tissues . PAHs including BP, a well-recog-
nized ca rcinogen, are known to be metabolized by various ma m-
malian cells [10,37,42-45]. The activation and inactivation path-
ways are major determinants of the formation and retention of 
toxic and/or ca rcinogenic cellular metabolites. In addition to th ese 
metabolic pathways other processes such as the extent of carcin-
ogen binding to macromolecules including DNA and the enzy-
mati c repair of damaged DNA are also important factors in the 
development of BP carcinogenesis [46 ,47]. It is presumed that 
certain specific sites in the target tissue DNA when modified by 
the carcinogen, ultimately lead to the formation of tumors whereas 
other sites in DNA which can also react with the electrophilic 
metabolites are less important in this regard . An explanation for 
these differences remains to be defined. 
The data in this paper indicate that the addition of c1otrimazole 
to cultured mouse keratinocy tes substantially inhibits AHH and 
ECD activities. Furthermore, HPLC anal ysis of BP metabolites 
in the culture medium and in the keratinocytes themselves in-
dicated that these cells metabolize BP to a series of metabolites. 
The metabolic profiles of BP as observed by DiGiovanni et al 
[37] in cultures of primary mouse epidermal cells and in untrallS-
formed and transformed epidermal cells were similar to those 
observed in the present study. However, we observed a number 
of differences between the metabolites of BP that could be iden-
tified within the cells and those found in the culture medium, A 
higher percentage of free phenols was found intracellulary and 
the ratio ofBP-7,8-diol to BP-9,10-diol was considerably greater 
than 1, whereas it was less in the culture medium. This suggests 
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Figure 2. Effect of clotrimazole on the intracel lular metabolism of BP 
in mouse keratinocytes. A, After incubations were performed as described 
in Materials mId Methods, cell homogenates were obtained . An organic 
extract of these homogenates was applied to HPLC for ana lysis. H, After 
incubations, ce ll homogenizations and organic extract ions were per-
formed, the remaining aqueous material was treated with ,B-glucuronidase 
to release glucuronide-conj uga ted metabolites (see text for specifi c de-
tails). An organic extract of these conjugates was applied to HPLC fo r 
analysis. C, After incubations, cell homogeniza tions and organic extrac-
tions were performed, and the remaining aqueous material was treated 
with aryl sulfa tase to release sul fate-conj uga ted metabolites. An organic 
extract of these conjugates was app lied to HPLC for ana lysis (see text fo r 
specific deta ils) . Profiles represent average va lues of quadrup licate samples 
which agree within 10% of the values shown. 
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Figure 3. Effect of clot ri mazolc on the ext racellular metabolism of BP 
in mouse keratinocytes, A , After incubations wcre performed as described 
in Materials mid I\!/ethods, an o rganic extract of the cultured medium was 
obtained. T his extract, representing the cell ular rele;\se of BP metabolites , 
was applied to HPLC for ana lysis . B, Afte r incubations and organic ex-
tractions of the culture mcdia were pcrformed, the remaining aqueous 
material was trcated w ith ,B-glucuronidasc to release glucuron ide-con-
jugated metabolites (sec text for specific details). C, Aftcr incubations and 
o rganic extractions of thc culturc mcdia wcre performcd, the remaining 
aqueous materia l was trcated with ary l sulf.ltase to release sul fate- con-
jugated metabolites (see text for specific details), 
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Figure 4. Effect of ciotrim JZolc on bindin g of r3 Hll:3p to mOliSc kcra-
tinocyte DNA and protein . After in cubations and ce ll ho mogeniza tions 
we re performed, cither the DNA was extracted from the ce lls or the 
protein was precipitated by adding 10% T C A (sec tex t for specific details). 
The extent ofBP-binding to keratinocyte DNA or protein fro l11 2 sepa rate 
expe rim ents is represented. 
that the 9, 10-dio l can m ove rapidl y frol11 th e cell s into the m e-
d ium . Thi s differential distributi o n of dio l m etabo lites between 
th e culture m edium and the cells has also been o bserved for BP 
in transfo rm ed m o use epide rmal cell s [37] and in hepatocytes 14S]. 
The structural fea tures o f th e 9, 1 O-dio l w hi ch confer this unique 
distribution pattern rem ain unknown alth o ug h differen ces in po-
lar ity appa rentl y do not explain the m a rked differen ces in its 
distribution [4S] . However, hydroxy l group confo rmatio n may 
play an impo rtant role in the distributi o n of dih ydrodio l m etab-
o lites between cell s and culture m edia [S]. 
Our res ults also indi ca te th at c1otrim3zole is a potent inh ibitor 
of BP m etabolite fo rmati o n in cultured keratinocy tes . Further-
m o re, clo trim azole has a g rea ter inhibito ry effect in BA- indu ced 
kera tinocy te microso mes o n BP m etabolism as co mpared w ith 
untreated co ntrol ce ll s. The fo rm atio n ofBP-7,S-dio l, a precurso r 
of th e ultim ate ca rcin ogen ic m e tabo lite o fBP, was inhibited 73% 
in BA- induced ke ratin ocy tes by c1 o trim azo k w hereas in co ntro l 
cells o nly 3S% inhibition occurred. These data in d ica te that clo-
trima zo le ma y have a g reater inhibitory effect o n the indu ced 
enzy m e, su gges tin g that this compound could be a po tent inhib-
itor ofPAH-i ndu ced skin tUlllori genes is. In othe r studi es we have 
shown that c1 o trimazolc is a potent inhibi to r o f 3-M C -induced 
skin tumori genes is .in BALB/c mi ce 130]. H o w ever, th e effec-
tiveness of c1otrimazo lc in inhibiting BP o r BP m etabo lite-in-
du ced sk in tum o ri genesis has no t been studied . 
We also found th at BP was converted to water-soluble metab-
o lites that could be extracted fro m th e cell s o r from th e extra-
cellular medium after treatm ent w ith .a-g lu curo nidase (prim ari ly 
3-0H-BP) and to a lesser ex tent with ary l sul fatase (primaril y 
BP-7 ,8- diol). In cultured ham ster trachea, it has been shown that 
smaller quantities of g lu curo nides are fo rm ed w ith BP- 4,5-d io l 
and BP-9, lO-diol as compared w ith other cells [43]. O n the o ther 
hand , hamster embryo cell s have been shown to produce g lu c-
uronides primaril y of 9-0H-BP, w hile sm all er qu antities o f 3-
OH-BP g lucuronide conjuga tes were a lso formed [49] . Treatment 
of the cultured ke rat inocyte o r the cell m edia with ary l sul fatase 
resulted in th e release of free m etabolites of BP, primaril y the 
7,8-diol , both in the cells and in the m edia. This is in agreem ent 
with the results of D iG iova nni ct al 137] usin g m o use epiderm al 
cells. In contras t w ith o ur res ults, Autrup et al [43] have shown 
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th at sul fate es ters and presum ab ly g lutathio ne conju ga tes are th e 
maj o r wa ter-solubl e m etabo lites of BP produced by tracheo-
bro nchi al tissues derived from mi ce, rats, ham sters, and hum ans. 
In o ur ke ratinocyte sys te m it is quite poss ibl e that the rad ioactivity 
rem ainin g in th e aqueous m edia after extractio n w ith .a-g lu cu-
ro nidase and ary l sulfatase (dat:l no t show n) m ay rcpresent g lu-
tathion e conju ga tes o f po lyhydroxybted deriV'Jtivcs of BP (e.g., 
te tro ls) . C lo trim azolc also d imini shcd the fo rm atio n of g lucuro-
nide and sulfate conj ugates of BP m etabo lites in the keratinocy tes 
and cell m edi a. T hese results arc not surprisin g as there is less 
fo rm ati o n of o rgani c solvent-so lubl e metabolites of BP both ex-
tracellu b rl y and in tracellularl y in the presence of clotrimazole . 
Kahl et al [2611~ ave show n tin t clotr im 3zolc is a poten t inhibitor 
of hepati c drug m eta bo li zin g enzy m es and of TIP-DNA add uct 
formation . Thc inhibi to ry effects of c1otrimazolc m ay relate to 
th e presence of the imidazo le rin g in its stru cture. Furtherm o re, 
certain other imidazo le deri vatives have been shown to inhibit 
hepatic and pulm o nary 1l1 0 nooxygenascs 127,281. Studi cs from 
o ur labo ra to ry have shown that c1otrimazolc is a potent inhibito r 
of P AH-in duced skin ca rcinogcnes is 130]. T he inhibito ry effect 
o f c1otr im 3zole on skin ca rcin ogenesis appea rs to be related to 
inhibition of th e mi croso m al m cta bolisIll of PAH and its sub-
sequen t bind in g to DNA 130 1. 
The data in this paper also suggest that clo trim azo le ca n inhibi t 
th e covalent bindin g of DP to m acro m olecu les in cluding DNA 
in cultured m o use kerat in ocytes. It is gcnerall y agreed that the 
bindin g of hydrocarb o ns and / o r th ei r m etabolites to D NA rep-
resents th e cru cial s tep in the c:l rcin ogenes is of P A H s [1 2, 131. A 
pos iti ve relat io nship between the ability of a ca rcin ogen to alk y late 
o r ary late DNA and its potency as a tumorigeni c :lgent has been 
shown 150,5 1] . It is un clear w hether the chc m o preventi ve effect 
of c1ot rim azole in any way rela tes to its abilit y to inhibit DNA 
binding of PAHs. 
In summary, o ur data in d icate tint cultured kcrat in ocytes from 
BALBlc m o use epidermis arc an impo rtant sys te m for assess in g 
ca rcin ogen m eta bo lism and its inhibitio n in the skin . T he imida-
zo le alltifunga l c1 o trim azole substantia ll y redu ces the fo rm atio n 
of ca rcin ogeni c m etabo lite(s) 3nd thi s m ay exp lain the p ro tective 
effects of c1otrim3zole aga inst P A H-ind uced tumorigenes is in the 
skin . Further studi es are under W3Y to m o re precise ly define the 
m echanis m of the 3ntiwm o ri geni c effects of imidazoles such as 
clotri 111 azoic . 
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